What dose is most appropriate when treating a post-prostatectomy patient with positive margins in the adjuvant setting?   

Although the landmark randomized trials treated up to 64 Gy, there is data out of Italy suggesting that higher doses yield better biochemical control (https://www.ncbi.nlm.nih.gov/pubmed/19619960?dopt=Abstract). Can dose escalation be done safely in post-prostatectomy patients?



Answer from: Radiation Oncologist at Community Practice

Answer from: Radiation Oncologist at Academic Institution